AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 63 filers reported holding AKCEA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $280,000 | – | 11,925 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,100,768 | $72,713,000 | 1.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $743,000 | 0.28% |
| Motley Fool Asset Management LLC | 63,591 | $1,491,000 | 0.17% |
| ALTRINSIC GLOBAL ADVISORS LLC | 120,286 | $2,821,000 | 0.13% |
| Virtus ETF Advisers LLC | 11,730 | $275,000 | 0.06% |
| Hudson Bay Capital Management LP | 80,000 | $1,876,000 | 0.04% |
| FMR LLC | 12,239,489 | $287,016,000 | 0.03% |
| ALPS ADVISORS INC | 193,375 | $4,535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 11,925 | $280,000 | 0.03% |
| Sculptor Capital LP | 400,200 | $9,384,000 | 0.02% |